Low "quotient" Lp(a) Concentration Mediates Autoimmune Activation and Independently Predicts Cardiometabolic Risk

Creative Commons License

Onat A., Coban N., Can G., Yueksel M., KARAGOEZ A., Yueksel H., ...More

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.123, no.1, pp.11-18, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 123 Issue: 1
  • Publication Date: 2015
  • Doi Number: 10.1055/s-0034-1385922
  • Journal Name: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.11-18
  • Keywords: autoimmune activation, coronary heart disease, diabetes, type-2, impaired fasting glucose, lipoprotein(a), CORONARY-ARTERY-DISEASE, CARDIOVASCULAR-DISEASE, HEART-DISEASE, HYPERTRIGLYCERIDEMIC-WAIST, APOLIPOPROTEIN(A) GENE, PLASMA LIPOPROTEIN(A), MYOCARDIAL-INFARCTION, DIABETES-MELLITUS, SERUM CREATININE, FOLLOW-UP
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University-Cerrahpasa Affiliated: No

Abstract

Objective: We determined whether U-shaped relationships exist between serum lipoprotein[Lp](a) and cardiometabolic risk.